Literature DB >> 33728079

Development of Two Types of Skin Cancer in a Patient with Systemic Sclerosis: a Case Report and Overview of the Literature.

Firdevs Ulutaş1, Erdem Çomut2, Veli Çobankara1.   

Abstract

Systemic sclerosis (SSc) is an uncommon rheumatic disease in which the underlying main histopathologic feature is a thickening of the skin due to excessive accumulation of collagen in the extracellular tissue. Fibrogenesis, chronic inflammation, and ulceration may eventually promote skin neoplasms. Although nonmelanoma skin cancer (NMSC) is the most frequent type, there have been restricted case reports and case series with skin cancers in SSc patients in the literature. Herein, we describe a 78-year-old woman diagnosed with diffuse cutaneous systemic sclerosis thirteen years ago and associated nonspecific interstitial pneumonia that was successfully treated with high cumulative doses of cyclophosphamide. She developed basal cell carcinoma and squamous cell carcinoma of the skin in the follow-up. She is still on rituximab treatment with stable interstitial lung disease as indicated by pulmonary function tests and high-resolution chest computed tomography. To our knowledge and a literature search, this is the first reported patient with SSc with two types of skin cancer. In this review, we also aimed to emphasize the relationship between SSc and skin cancer, and possible risk factors for SSc-related skin cancer.
Copyright © 2021 Firdevs Ulutaş et al.

Entities:  

Year:  2021        PMID: 33728079      PMCID: PMC7935603          DOI: 10.1155/2021/6628671

Source DB:  PubMed          Journal:  Case Rep Oncol Med


  31 in total

Review 1.  Cyclophosphamide for connective tissue disease-associated interstitial lung disease.

Authors:  Hayley Barnes; Anne E Holland; Glen P Westall; Nicole Sl Goh; Ian N Glaspole
Journal:  Cochrane Database Syst Rev       Date:  2018-01-03

Review 2.  The expression of the renin-angiotensin-aldosterone system in the skin and its effects on skin physiology and pathophysiology.

Authors:  M Aleksiejczuk; A Gromotowicz-Poplawska; N Marcinczyk; A Przylipiak; E Chabielska
Journal:  J Physiol Pharmacol       Date:  2019-09-18       Impact factor: 3.011

Review 3.  Systemic sclerosis.

Authors:  Yoshihide Asano
Journal:  J Dermatol       Date:  2017-12-10       Impact factor: 4.005

4.  Systemic sclerosis and malignancy.

Authors:  Gokhan Sargin; Taskin Senturk; Songul Cildag
Journal:  Int J Rheum Dis       Date:  2018-04-19       Impact factor: 2.454

5.  A case of basal cell carcinoma of the skin in a patient with systemic sclerosis.

Authors:  J S Song; S K Bae; S Y Park; W Park
Journal:  Rheumatol Int       Date:  2000-12       Impact factor: 2.631

6.  [The evaluation of tumor histopathology, location, characteristic, size and thickness of nonmelanoma skin cancers of the head and neck].

Authors:  Görkem Eskiizmir; Erdoğan Ozgür; Peyker Temiz; Gülsüm Gençoğlan; Aylin Türel Ermertcan
Journal:  Kulak Burun Bogaz Ihtis Derg       Date:  2012 Mar-Apr

7.  Evaluation of cancer records from 2000-2004 in Denizli, Turkey.

Authors:  A Köksal; H C Sorkun; H Demirhan; A G Tomatir; T Alan; F Ozerdem
Journal:  Genet Mol Res       Date:  2009-01-27

Review 8.  Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature.

Authors:  Michele Colaci; Dilia Giuggioli; Marco Sebastiani; Andreina Manfredi; Caterina Vacchi; Paolo Spagnolo; Stefania Cerri; Fabrizio Luppi; Luca Richeldi; Clodoveo Ferri
Journal:  Autoimmun Rev       Date:  2012-06-25       Impact factor: 9.754

9.  Non-melanoma skin cancers between the years of 1990 and 1999 in Izmir, Turkey: demographic and clinicopathological characteristics.

Authors:  Can Ceylan; Günseli Oztürk; Sibel Alper
Journal:  J Dermatol       Date:  2003-02       Impact factor: 4.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.